Ji-Hyun Lee, DrPH, named associate director for cancer quantitative sciences

Ji-Hyun Lee, DrPH, has been elevated to a new role as associate director for cancer quantitative sciences. In this role, she will provide high-level strategic leadership and administrative direction for Cancer Center researchers. This support aims to ensure high-quality data, rigorous and reproducible analyses, and effective reporting, fostering collaborative team-based scientific endeavors.


Research Snapshot: Noninvasive blood testing method shows promise in evaluating liver cancer

UF Health researchers have shown in a pilot study that a noninvasive method of blood testing can effectively detect cancerous liver tumors and evaluate changes in the disease during treatment. The preliminary findings indicate that the technique, measuring methylated circulating tumor DNA, or ctDNA, could allow physicians to assess patients’ tumor burden without the need for invasive tumor biopsies.

Liver cancer


Genetic score advances personalized treatment strategies with promising AML drug

In the latest development in precision medicine approaches to treating pediatric leukemia, UF Health researchers have developed a genetic score to predict patient outcomes with a promising targeted drug treatment.